Price Capping of Medical Devices
Indian Economy › Industry, MSMEs and Industrial Policy · Topic 15.15
Price capping of medical devices means fixing a ceiling price or limiting price rises for devices under the Drugs (Prices Control) Order, 2013 (DPCO 2013), which the National Pharmaceutical Pricing Authority (NPPA) enforces. Since 1 April 2020 all medical devices are regulated as drugs and come under DPCO 2013. Four devices are scheduled and have ceiling prices: cardiac stents, drug eluting stents, condoms and intra-uterine devices (Cu-T). For all other devices, the NPPA monitors the maximum retail price (MRP) under Para 20 so that no manufacturer or importer raises it by more than 10 per cent in 12 months.
6 min read · UPSC Prelims and Mains · Indian Economy · Industry, MSMEs and Industrial Policy
At a Glance
- Regulator NPPA, Department of Pharmaceuticals
- Law Drugs (Prices Control) Order, 2013
- All devices under DPCO from 1 April 2020
- Scheduled devices Cardiac stents, DES, condoms, Cu-T
- Other devices MRP rise limited to 10 per cent in 12 months
- Stent ceiling (Feb 2017) Rs 7,260 BMS, Rs 29,600 DES
- Exam link UPSC Prelims and Mains, Indian Economy: Industry, MSMEs and Industrial Policy
Where Does It Fit?
This topic extends price regulation from medicines to devices. It sits beside the manufacturing view in Make in India launched 25 September 2014 PLI sectors 14, announced outlay Rs 1.97 lakh crore Approved outlay (July…">Make in India; Government Policies to Promote Manufacturing; Specialty Steel PLI; Production Linked Incentive Scheme, and the rules apply equally to devices made under incentive schemes such as Production Linked Incentive Scheme. Previous topic: Industrial Development Report (UNIDO); Global Innovation Index; Global IP Index. Next topic: Startup India Seed Fund Scheme; Standup India.
How Are Scheduled and Non-Scheduled Medical Devices Priced?
| Category | Devices | Price control rule |
|---|---|---|
| Scheduled devices | Cardiac stents, drug eluting stents, condoms, intra-uterine device (Cu-T) | Ceiling prices fixed by the NPPA. These four are under price control |
| Non-scheduled devices | All other devices notified or regulated as drugs | NPPA monitors MRP under Para 20(1) of DPCO 2013. No manufacturer or importer may raise MRP by more than 10 per cent of the MRP in the preceding 12 months |
| If the rise exceeds 10 per cent | Any non-scheduled device | The price must be reduced to the level of 10 per cent of MRP for the next 12 months |
| Overcharging | Any device under DPCO | Under Para 20(2) read with the Essential Commodities Act, 1955, the manufacturer or importer must deposit the overcharged amount with interest, in addition to penalty |
What Are the Landmark Price Caps and Notifications?
| Date | Step | Detail |
|---|---|---|
| 19 July 2016 | Stents in the essential list | The Ministry of Health and Family Welfare included coronary stents in the National List of Essential Medicines, 2015 |
| 21 December 2016 | Stents in Schedule I | Coronary stents were placed in Schedule I of DPCO 2013 |
| February 2017 | Stent ceiling prices | NPPA capped bare metal stents (BMS) at Rs 7,260 and drug eluting stents (DES) at Rs 29,600, excluding VAT and local taxes. With 5 per cent VAT the MRP is Rs 7,623 for BMS and Rs 31,080 for DES |
| August 2017 | Knee implants | NPPA capped the prices of knee implants, effective 16 August 2017, because of excessive trade margins |
| 11 February 2020 | Notification S.O. 648(E) | The Health Ministry notified that medical devices are drugs for regulation |
| 31 March 2020 | NPPA notification | All medical devices governed by DPCO 2013 from 1 April 2020. 24 classes of devices were already regulated as drugs |
| July 2020 | Critical equipment | NPPA called for price data on pulse oximeters and oxygen concentrators to ensure prices existing on 1 April 2020 did not rise more than 10 per cent in a year |
What Else Should You Remember?
- Also called: Medical device price control is also called price capping, price regulation or ceiling price fixation. NPPA stands for National Pharmaceutical Pricing Authority, functioning under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers. DPCO means Drugs (Prices Control) Order
- Trade margin: The trade margin is the gap between the price at which a manufacturer or importer sells to the trade and the MRP paid by the patient. Price capping targets excessive trade margins that raise the patient price far above the cost of supply
- Worked example: stent price fall: Before the cap the average MRP in the market was Rs 45,000 for BMS and Rs 1,21,000 for DES. After the cap the MRPs were Rs 7,623 and Rs 31,080. The fall for BMS is (45,000 – 7,623) / 45,000 = 83.1 per cent, and for DES (1,21,000 – 31,080) / 1,21,000 = 74.3 per cent. A patient with a DES saved about Rs 89,920. DES had 90 per cent of the market and BMS 10 per cent. The price with VAT check: 29,600 x 1.05 = Rs 31,080
- Government estimate of relief: The Government estimated an average benefit of Rs 80,000 to Rs 90,000 per stent and a gross relief of Rs 4,450 crore in one year
- Worked example: the 10 per cent rule: A non-scheduled device had an MRP of Rs 1,000 twelve months ago. The maximum allowed MRP is Rs 1,100. If a company sells at Rs 1,250, the increase is 25 per cent, which is beyond 10 per cent, so the price must be brought back to Rs 1,100 for the next 12 months and the overcharge may be recovered with interest
- How ceiling price is set for medicines: Under DPCO 2013 the ceiling price of a scheduled formulation is the simple average of the price to retailer of brands with at least 1 per cent market share, plus 16 per cent retailer margin. In formula form, Pc = Ps x (1 + M / 100) with M = 16. For example, an average price to retailer of Rs 100 gives a ceiling price of Rs 116
- Why devices were brought in: Devices were earlier outside the price regime except for a few items. From 1 April 2020 all devices are regulated as drugs for quality control and price monitoring, so the NPPA can monitor every device MRP
- Links: The industrial policy behind domestic device production is in Make in India; Government Policies to Promote Manufacturing; Specialty Steel PLI; Production Linked Incentive Scheme, and the broader price controls on essentials are in Essential Commodities Act; Contract Farming; Agricultural Produce and Livestock Marketing Acts (APLM Act 2017)
Why Does It Matter for the Exam?
- Four scheduled devices: Cardiac stents, drug eluting stents, condoms and Cu-T
- Para 20: The rule that limits MRP increases to 10 per cent in 12 months applies to non-scheduled items
- Stent prices: Rs 7,260 BMS and Rs 29,600 DES before taxes. Questions often check which stent is capped at which price
- Date: All devices under DPCO from 1 April 2020
- Common error: Saying that all devices have ceiling prices. Only four are scheduled, and the rest face the 10 per cent monitoring rule
As an analytical point, capping the price of a few high-volume essential devices and monitoring the rest balances patient affordability and industry incentives. Transparent margins would reduce the need for repeated caps.
Why Is This Topic Important?
- Regulator NPPA and DPCO 2013
- Scope 4 scheduled, others monitored
- Stents Rs 7,260 and Rs 29,600
What Came Next?
The next topic covers the two schemes for entrepreneurs, the Startup India Seed Fund Scheme and Stand-Up India. Next topic: Startup India Seed Fund Scheme; Standup India.
Key People and Terms
- NPPA Price regulator for drugs and devices
- DPCO 2013 Drug price order
- Ceiling price Maximum price allowed
- Scheduled device Has a ceiling price
- MRP Maximum retail price
- Trade margin Gap between trade price and MRP
Exam Corner
Points to Remember
- Four scheduled: stents (BMS, DES), condoms, Cu-T.
- Others: MRP rise limit 10 per cent in 12 months.
- All devices under DPCO from 1 April 2020.
- Stent caps: Rs 7,260 and Rs 29,600.
- Regulator: NPPA.
Do Not Confuse With
- Scheduled and non-scheduled devices Ceiling price versus 10 per cent monitoring
- DPCO 2013 and Drugs and Cosmetics Act Price order versus the law that classifies devices as drugs
- Ceiling price and MRP Maximum allowed versus printed retail price
Memory Hook
Four get a ceiling, the rest get a ten per cent leash.
Mains Angle
Questions on medical device pricing ask for rules and balance. These points give a frame.
- Need High margins and out-of-pocket cost
- Rules Ceiling and 10 per cent
- Way Cap essentials, build domestic supply
A Question You May Face
An original practice question, not a past paper question.
“Examine the case for and against price capping of medical devices in India.”
How to Answer
- Define NPPA and DPCO.
- Facts Four scheduled, stents.
- Debate Affordability and supply.
- Way Targeted caps.
GS Relevance
Frequently Asked Questions
Who regulates the price of medical devices in India?
The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, regulates the price of medical devices under the Drugs (Prices Control) Order, 2013. All medical devices have been regulated as drugs for quality control and price monitoring since 1 April 2020.
Which medical devices have price ceilings in India?
Four scheduled devices have ceiling prices: cardiac stents, drug eluting stents, condoms and intra-uterine devices (Cu-T). All other devices are non-scheduled, and the NPPA monitors their MRP under Para 20 of DPCO 2013 so that annual price rises stay within 10 per cent.
What is the 10 per cent rule for medical devices?
Under Para 20(1) of DPCO 2013, no manufacturer or importer can increase the MRP of a non-scheduled device by more than 10 per cent of the MRP in the preceding 12 months. If the rise is greater, the price must be cut back to the 10 per cent level.
What is the price cap on coronary stents?
In February 2017 the NPPA capped bare metal stents at Rs 7,260 and drug eluting stents at Rs 29,600, excluding VAT and local taxes. With 5 per cent VAT the MRPs are Rs 7,623 and Rs 31,080, down from average MRPs of Rs 45,000 and Rs 1,21,000.
How is the ceiling price of a scheduled drug calculated?
The ceiling price is the simple average of the price to retailer of brands with at least 1 per cent market share, plus 16 per cent retailer margin, as in Pc = Ps x (1 + 16/100). An average price to retailer of Rs 100 gives a ceiling price of Rs 116.
PYQ Practice — Statement Analysis
1 Cardiac stents, drug eluting stents, condoms and Cu-T are scheduled devices with ceiling prices.
All other devices face the 10 per cent MRP monitoring rule.
2 All medical devices came under DPCO 2013 from 1 April 2020.
As notified by the NPPA on 31 March 2020.
3 The NPPA is a body under the Ministry of Health.
It functions under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers.
4 The ceiling price of a drug adds 16 per cent retailer margin to the average price to retailer.
Formula: Pc = Ps x (1 + M/100) with M = 16.
Related Topics
Browse the full Indian Economy index